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Summary Transcriptional activator interferon regulatory factor (IRF)-1 and repressor IRF-2 are known to play a critical role in the regulation
of interferon (IFN) responses and oncogenesis in fibroblasts. Although these two factors are expressed in many tissues, including the brain,
the role of IRFs in the central nervous system (CNS) has not been elucidated. We analysed a medulloblastoma cell line, ONS-76, as a CNS-
derived model system and generated its derivatives, Rl and R2 cells, which constitutively expressed each mouse IRF-1 and IRF-2 cDNA at
high levels. By viral infection, Rl and R2 cells showed IFN-4 gene expression 3 h earlier than the control ONS-76 (C-76) cells, with 2.46- and
2.24-fold increase in IFN-,B production respectively. In the presence of cycloheximide, virally induced IFN-, gene expression of C-76 cells was
suppressed, whereas Ri and R2 cells produced IFN-P 7.5- and 2.2-fold higher than C-76 cells respectively. On the other hand, induction of
IFN-inducible genes was enhanced in Ri cells but was suppressed in R2 cells compared with C-76 cells. These results demonstrate that
IRF-1 and IRF-2 may play an important role in the regulation of IFN-,B and IFN-inducible genes and that IRF-2 may have dual functions as
an activator and repressor in CNS-derived cells.
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Interferons (IFNs) are well-characterized cytokines that play
important roles in host defence against viral infection and in regu-
lation of cell growth and differentiation of various types of cells
(Weissman and Weber, 1986; Pestka et al, 1987; Vilcek, 1990). In
the central nervous system (CNS), glia and glioma cells produce
IFNs by viral infection and polyribonucleotide induction when
IFNs activate IFN-inducible genes (Wong et al, 1984; Tedeschi et
al, 1986). In addition, IFNs can enhance the excitability ofcultured
neurons (Calvet and Gresser, 1979) or inhibit synaptic potentiation
in the tissue culture of hippocampus (D'Arcangelo et al, 1991).
Thus, IFNs manifest multiple biological activities in the CNS.
In the process ofstudying the mechanism ofIFN responses, two
nuclear factors, interferon regulatory factor-1 (IRF-1) and IRF-2,
were identified and analysed (Miyamoto et al, 1988; Harada et al,
1989). These two factors are structurally related and bind to the
same regulatory cis elements within the promoters of type 1 IFN
(IFN-c/p) and IFN-inducible genes (Miyamoto et al, 1988;
Harada et al, 1990; Tanaka et al, 1993). Transfection analysis with
type 1 IFN cDNAs showed that IRF-I acts as a transcriptional
activator in the IFN system, whereas IRF-2 acts as a repressor of
IRF-1-mediated activation (Fujita et al, 1989a; Harada et al,
1990). Recent studies using IRF-1-gene-disrupted mice have
shown that IRF-1 is a critical regulator for antiviral and antibacte-
rial functions ofIFNs (Kamijo et al, 1994; Kimura et al, 1994). On
the otherhand, IRF-1 and IRF-2 manifest antioncogenic and onco-
genic potentials, respectively, by transformation assays using NIH
3T3 cells (Harada et al, 1993). Furthermore, IRF-1 is regarded as a
tumour suppressor from the evidence that embryonic fibroblasts
lacking IRF-I are susceptible to oncogenic transformation by the
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activated c-Ha-ras gene alone (Tanaka et al, 1994). IRF-1 also
regulates DNA damage-induced apoptosis in ras-expressing
fibroblasts or mitogen-activated T lymphocytes (Tamura et al,
1995). Thus, IRF-1 and IRF-2 function as regulators not only in
IFN responses, but also in a broad range ofcellular reactions.
Nevertheless, although IRF-1 is known to be expressed in the
brain (Miyamoto et al, 1988), the function of IRF-1 and IRF-2 in
the CNS is not yet understood. Investigation ofIRF function in the
CNS may be important to understand the regulation ofhost defence
against viral and bacterial infections and oncogenesis in the CNS.
Medulloblastoma cells have been described as undifferentiated
CNS-derived cells that may differentiate into neuronal and/or glial
cells (Rubinstein, 1985; Valtz et al, 1991). Previously, we have
established a medulloblastoma cell line, ONS-76, with neuronal
characterization in cytoskeletal proteins (Tamura et al, 1989;
Yamada et al, 1989). Here, we used this cell line to examine IRF
function in the CNS because most of the neuroblastoma cell lines
are derived from peripheral nervous system and other CNS-derived
ones are generally established from glioma. We generated stable
transfectants of ONS-76 cells overexpressing mouse IRF-1 and
IRF-2 cDNA, and first analysed the well-characterized action of
IRF-1 and IRF-2, i.e. regulation ofIFN and IFN-inducible genes.
MATERIALS AND METHODS
Cell culture
ONS-76 cells were established from a surgical specimen of cere-
bellar tumour, pathologically diagnosed as medulloblastoma, from a
2-year-old girl using the primary explant technique (Yamada et al,
1989). The cells were cultured in RPMI-1640 medium supplemented
with 10% fetal bovine serum (FBS) and 4 mm glutamate at 37°C in
5% carbon dioxide. The cells were detached fromculture dishes with
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0.05% trypsin and 0.02% EDTA and were replated for expansion.
The cells at 33-36 passages were used for the present study.
Detection of IFN-f production
For production of IFN-P, poly(I):poly(C) (Dako) was added to
monolayer cells at the concentration of 100 tg ml in the presence
of DEAE-dextran (500 ,ug ml-') for 1 h in phosphate buffer solu-
tion (PBS). Six hours after the treatment with poly(I):poly(C), the
supernatants were harvested for determination of IFN yield. Virus
induction was performed by infection with Newcastle disease
virus (NDV), as previously described (Fujita and Kohno, 1981).
The concentrations of IFN-3 in supernatants were determined in
enzyme-linked immunosorbent assay (ELISA) kits (Toray-Fuji
Bionics, Tokyo, Japan). The microtitre plates were coated with
a murine monoclonal antibody to human IFN-f. The standard
contained recombinant human IFN-P (Toray). Samples of super-
natants were pipetted into the wells. After washing, an enzyme-
linked murine monoclonal antibody specific for human
IFN-4 (Dako) was added. After washing to remove unbound anti-
body-enzyme reagent, a substrate solution was added. Colour
developed in proportion to the concentration of IFN-3 bound in
the initial step. Absorbency at 450 nm was measured using an
ELISA reader. For IFN stimulation, recombinant human IFN-3
(Toray, Tokyo) was added to the culture media at the concentration
of 3x 102or3x l0- Umlrn.
Retrovirus-mediated gene transfer and selection of
stable transfectants
Recombinant retroviruses pGDIRFl and pGDIRF2 were
described previously (Harada et al, 1993). To obtain cell clones
overexpressing IRF-1 or IRF-2, ONS-76 cells were transfected by
recombinant retrovirus pGDIRF-1, pGDIRF-2 or pGD as control
[multiplicity of infection (MOI) 10] with 8 [tg ml' polybrene
to culture media. After 94-h inoculation, the culture media
containing retrovirus were removed and ONS-76 cells were
cultured for 2 days, then followed by 600,g ml-' G418
(neomycin; Gibco, Grand Island, NY, USA) selection for 2 weeks.
More than 105 clones were obtained after transfection ofpGDIRF-
1 (R1), pGDIRF-2 (R2) and pGD (C-76). Expression of the IRF- 1
and IRF-2 mRNAs and protein contents in these transfectants were
confirmed by Northern blot and gel-shift analysis.
Northern blot analysis
Cells were washed twice with PBS and total RNA was extracted
(Harada et al, 1990). Northern blot analysis was carried out
according to the method ofChurch and Gilbert (1984). To prepare
probes, the following DNAs were labelled by the multiprime DNA
labelling reaction (Amersham): mouse IRF-1, a 1.8-kb EcoRI
fragment from L28-8 (Miyamoto et al, 1988); human IRF-1, a
0.65-kb NcoI-KpnI fragments of pHIRF-31 (Maruyama et al,
1989); mouse IRF-2, a 1.4-kb XbaI fragment from pIRF2-5
(Harada et al, 1989); human IRF-2, a 1.4-kb XbaI fragment from
pHIRF4S-51 (Itoh et al, 1989); and human IFN-f probe is the
same as described previously (Miyamoto et al, 1988). 2'-5'
oligoadenylate (2-5 A) synthetase, a 1.3-kb BamHI fragment from
pE22-1 (Shiojiri et al, 1986) was kindly provided by Dr Y
Sokawa, Kyoto Institute ofTechnology. Specific activities ofall of
the probes were similar.
Table 1 IFN-P production in C-76, Ri and R2 cells
Interferon yield (units per 106 cells)a
Induction C-76 Rl R2
None <5 <5 <5
IFN-lb <5 <5 <5
virusc 252 615 572
IFN-,Bb + poly(l):poly(C)c 238 570 442
aIFN yields in the culture media were determined by an ELISA for human
IFN-f3 (Toray, Tokyo). Similar results were obtained in three separate
experiments. bCultures were treated with human IFN-,B (1000 U ml-': Toray,
Tokyo, Japan) for 3 h. Thereafter the cells were washed with PBS, and the
supernatants were harvested for determination of IFN yields. cln case of viral
infection, IFN yields were determined in culture fluids harvested 18 h after
inoculation with Newcastle disease virus. dCultures were exposed to medium
with poly(l):poly(C) (100,g ml-') in the presence of DEAE-dextran
(500 mg ml-') for 1 h. Six hours after the treatment with poly(l):poly(C), the
supernatants were harvested for determination of IFN yields.
Table 2 Mean fluorescence intensities for uninduced and IFN-induced cell
clones as indicated in Figure 6
Mean fluoresence intensity Fold inductiona
Cell IFN-f induced B/A C/A
Uninduced 300 U ml-' 3000 U ml'
C-76 4.05 6.10 7.04 1.51 1.74
Rl 6.22 8.25 23.2 1.33 3.73
R2 2.95 3.17 4.71 1.07 1.60
aFold inductions were calculated by dividing the mean fluorescence
intensities of IFN-induced cells by those of uninduced cells.
Gel-shift analysis
Cells were suspended in lysis buffer (20 mm Hepes, pH 7.9;
50 mm sodium chloride; 10 mm EDTA; 2 mM EGTA; 10 mM
sodium molybdate; 10 mm sodium orthovanadate; 100 mm sodium
fluoride; 0.1% NP40; 0.5 mm phenylmethylsulphonyl flouride
(PMSF); 100 tg ml-' leupeptin). The suspensions were sonicated
for 2 min and centrifuged at 12 000 r.p.m. for 10 min. The super-
natant was used as cell extract. Then, gel-shift assays were
performed as follows. Two microlitres of the partially purified
antibodies (anti-IRF-l, 5.5 mg ml-'; anti-IRF-2, 5.5 mg ml-') and
20 mg of protein from the cell extracts were incubated on ice for
60 min. 32P-labelled Cl oligomer (4 fml, 3000 c.p.m. fmol-')
(Harada et al, 1990), 1 mg of herring sperm DNA, and 2 mg of
poly (I): poly(C) were then added and incubated at 25°C for
60 min in a final volume of 10 ml containing 10 mm Tris-HCl
(pH 7.5), 50 mm sodium chloride, 1 mM dithiothreitol (DTT),
1 mM EDTA and 5% glycerol. Electrophoresis was performed as
described previously (Harada et al, 1990).
Flow cytometric analysis
Cells were grown to confluence in 25-cm2 plastic flasks and
treated with IFN-1 (300 or 3000 U ml') for 24 h. Cells were
harvested by vigorous pipetting and were resuspended in ice-cold
buffer (PBS with 5% FBS and 0.5% sodium azide). The cells were
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Figure 1 Induction of IRF-1 and IRF-2 mRNAs by IFN-jI stimulation and
viral infection. ONS-76 cells were treated with 103 U ml-1 IFN-P for 1 h or
NDV for 1 h. Five micrograms of total RNA isolated from cells at several time
intervals after each induction were subjected to Northern blot analysis. The
filters were stained with methylene blue to show 28S ribosomal RNA and
then probed with IRF-1 or IRF-2
incubated with 1:1000 diluted monoclonal antibody against MHC
class I antigens (Bio-Rad, Richmond, CA, USA) for 30 min at 40C
and then washed three times with the buffer. The cells were then
incubated in a 1:100 dilution of goat anti-mouse IgG conjugated to
fluorescein isothiocyanate (Sigma, St Louis, MO, USA) in the
buffer for 30 min at 4°C. Thereafter, the cells were washed three
times in ice-cold PBS and analysed on an EPICS Elite flow
cytometer (Coulter, Hlaleah, FL, USA).
RESULTS
Induction of IRF-1 and IRF-2 mRNAs in ONS-76 cells
To examine the induction of IRF-1 and IRF-2 genes in CNS-
derived cells, ONS-76 cells were incubated for different time
periods after IFN-,B stimulation or viral infection, and levels of
IRF- 1 and IRF-2 mRNA were determined by Northern blot
analysis. As shown in Figure IA, after IFN-4 stimulation a rapid
increase for IRF- 1 and IRF-2 mRNA was observed, with
maximum inductions at 6 h for IRF-1 and 3 h for IRF-2. This
result differed from the previous reports of fibroblasts in which
IRF- 1 was induced very quickly after IFN-3 stimulation (Fujita et
al, 1989b; Harada et al, 1989; Reis et al, 1992). Under NDV infec-
tion, IRF- 1 and IRF-2 genes were induced more slowly than under
A
1 2 3 4
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IFN-1 stimulation, and both induction levels peaked at 9 h after
infection as shown in Figure lB. This evidence was in agreement
with the previous reports offibroblasts (Fujita et al, 1989b; Harada
et al, 1989; Reis et al, 1992). These results indicate that IRF-l and
IRF-2 mRNA were expressed by IFN-3 stimulation and viral
infection in CNS-derived cells as well as fibroblasts, apart from
the delayed induction of IRF-1 after IFN-3 stimulation.
Generation of IRF-1 or IRF-2 overexpressing ONS-76
cells
To gain further insight to the function ofIRF-1 and IRF-2 in ONS-
76 cells, we generated stable transfectants of ONS-76 cells over-
expressing mouse IRF-1 or IRF-2 cDNA by using recombinant
retroviruses. To eliminate the effect of IRF-1 and IRF-2 caused by
clonal variants, we mixed approximately 105 clones and analysed
the average effect of IRF-1 or IRF-2. The expression of trans-
genes, mouse IRF-l and IRF-2, was detected in RI (mixture of
IRF-1 introducing clones) and R2 (mixture of IRF-2 introducing
clones) cells by Northern blot analysis (Figure 2A). We used C-76
cells (mixture ofno inducing clones) as control. Then, we analysed
IRF-1 or IRF-2 expression for protein level by gel-shift analysis.
As shown in Figure 2B, there were two bands ofIRF-1 and IRF-2,
in agreement with the results in fibroblasts (Harada et al, 1989;
1990). The DNA-binding activity of IRF-1 in RI cells was 7.3-
fold and that of IRF-2 in R2 cells was 8.2-fold higher than C-76
cells when analysed using a densitometer (Fuji film, Tokyo,
Japan). In this study, we detected a slower migrating band reactive
to anti IRF-2 antibody that was not detected in fibroblasts (Figure
2B). There was no alternation in cell growth, morphology and
cytoskeletal protein markers among parental ONS-76, C-76, R1
and R2 cells (data not shown).
IFN-P production and expression of IFN-,B gene in Rl
and R2 cells
Without orwithIFN-P stimulation, there were no detectable levels of
IFN-P production in C-76, RI and R2 cells using ELISA (Table 1).
No detectable production of IFN-f in RI cells after IFN treatment
was in agreement with results in stable transfectants overexpressing
B C-76 RI R2 m m m, I
1 2 3 4 5 6 7 8 9
IRF-1
IRF-2
I I I I J
anti IRF-1 - + - - + - - +
anti IRF-2 - - + - - + - - +
Figure 2 Expression of transfected mouse IRF-1 and IRF-2 cDNAs in Ri and R2 cells. (A) Northern blot analysis of RNAs from R2 (lane 1), Ri (lane 2), C-76
(lane 3) and mouse fibroblast L929 (lane 4) cells. Five micrograms of total RNA was subjected to Northern blot analysis. (B) Autoradiogram of gel shift analysis.
Cell extracts were prepared from C-76 (lanes 1-3), Ri (lanes 4-6), and R2 (lanes 7-9) cells. Twenty micrograms of protein was subjected to gel shift analysis in
the presence of anti IRF-1 (lanes 2, 5 and 8) or anti IRF-2 antibodies (lanes 3, 6 and 9)
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Figure 4 Induction of IFN-P mRNA in C-76, Ri and R2 cells by viral
infection in the presence of cycloheximide. C-76, Ri and R2 cells were
treated with 100 mg ml-' cycloheximide, 1 h before NDV infection. Eleven
hours after NDV infection, each 5 9g of total RNA was subjected to Northern
blot analysis. The filters were stained with methylene blue to show 28S
ribosomal RNA and then probed with IFN-j. aDensitometric indexes (Dl) were
calculated by subtracting no induction levels (*) from IFN-,B mRNA levels
measured using densitometry
A 2-5Asynthetase 28 rRNA
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Figure 3 IFN-f expression in Rl and R2 cells. (A) IFN-,B mRNAs in C-76,
Rl and R2 cells after NDV infection. Five micrograms of total RNA isolated
from the cells at several time intervals after treatments with NDV for 1 h were
subjected to Northern blot analysis. The filters were stained with methylene
blue to show 28S ribosomal RNA and then probed with IFN-3. (B) The IFN-,B
mRNA levels of B were quantified using densitometric analysis. ---) - -,
C-76; -+- R1; -A, R2. The peak expression level of C-76 cells was assigned
the value of 1.0 in each graph
IRF- 1 derived from other cell types (Leblanc et al, 1990; Reis et al,
1992). Under viral induction, RI and R2 cells produced 2.46- and
2.24-fold higher IFN-f than C-76 cells, and under poly(I): poly(C)
stimulation afterIFN-P priming, RI and R2 cells produced 2.33- and
1.87-fold higher IFN-P than C-76 cells respectively (Table 1). To
examine whether overexpression of IRF-1 or IRF-2 affects IFN-1
production at transcriptional levels, total RNA extracted from C-76,
RI and R2 cells every 3 h after viral infection were subjected to
Northern blot analysis (Figure 3A). The induction ofthe IFN-, gene
in both RI and R2 cells was detected 3 h earlier than that of C-76
cells, and the rate ofdecrease after maximal induction was slower in
R1 and R2 cells than in C-76 cells using densitometric measurement
(Figure 3B). However, there was no significant difference in the
magnitude of maximal induction in C-76, RI and R2 cells (Figure
3B). These results indicate that not only IRF-1 but also IRF-2 over-
expression in ONS-76 cells up-regulated the expression ofthe IFN-3
gene by viral infection or double-stranded RNA stimulation.
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Figure 5 Expression of 2-5 A synthetase mRNA induced by IFN-,B. (A) The
cells were treated with 103 U mlI- IFN-f for 1 h. Five micrograms of total RNA
isolated from cells at several time intervals after IFN-,B stimulation were
subjected to Northern blot analysis. The filters were stained with methylene
blue to show 28S ribosomal RNA and then probed with 2-5 A synthetase. (B)
mRNA levels of 2-5 A synthetase were quantified using densitometric
analysis. -- 0 - -, C-76; -0-, R1; -A-, R2
IFN-P expression in Rl or R2 cells in the presence of
cycloheximide
To examine whether or not de novo protein synthesis is necessary
for IFN-P expression after viral infection, C-76, RI and R2 cells
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Figure 6 Induction of cell-surface expression of MHC class antigens by IFN-f. C-76, Rl and R2 cells were treated for 48 h without or with recombinant
human IFN-1 (300 or 3000 U ml-1; Toray, Tokyo, Japan). The cells were then incubated with a mouse monoclonal antibody against MHC class antigen.
Thereafter, the cells were incubated with a goat anti-mouse antibody conjugated to FITC. Cell-surface staining was quantified using EPICS Elite Flow
Cytometer. Histograms depict fluorescence profiles of uninduced (-) and IFN-induced (--- -) cells. Zero point of fluorescence intensity is normalized at that of
cells treated only with a goat anti-mouse antibody conjugated to FITC
were continuously treated with 100 mg ml cycloheximide (CHX),
a protein synthesis inhibitor, 1 h before viral infection. Eleven
hours after viral infection, when there was no significant difference
in IFN-P gene expression in C-76, RI and R2 cells (Figure 3B),
total RNAs prepared from cells were applied to Northern blot
analysis. As shown in Figure 4, in the presence of CHX virally
induced IFN-0 expression of C-76 cells was completely
suppressed. However, that of RI or R2 cells similarly treated with
CHX showed 7.5- or 2.2-fold higher IFN-P expression, respec-
tively, than C-76 cells using densitometric measurement (Figure 4).
These results indicate that pre-existing IRF-1 and IRF-2 before
CHX treatment up-regulated virally inducedIFN-0 expression, and
in particular IRF-I was much more effective than IRF-2.
Regulation of IFN-inducible genes in Rl and R2 cells
The possible roles ofIRF-l and IRF-2 in the transcriptional regula-
tion of IFN-inducible genes were extensively analysed (Harada et
al, 1989; Watanabe et al, 1991; Matsuyama et al, 1993). Among the
IFN-inducible genes known to contain IRF-binding domains in
their promoter regions are the genes for 2-5 A synthetase and MHC
class I antigens. Constitutive expression of IRF-1 mRNA in the
sense or antisense orientation in human fibroblasts (GM637)
demonstrated enhancement or suppression of the expression of
IFN-inducible genes respectively (Reis et al, 1992). In this study, by
using stable transfectants overexpressing IRF-1 or IRF-2 mRNA,
we found a reciprocal role of IRF-1 and IRF-2 in the regulation of
the expression of these genes. The levels of 2-5 A synthetase
mRNA were determined by Northern blot analysis after C-76, RI
and R2 cells were exposed for different time periods to IFN-3. As
shown in Figure SA, three bands, 3.6, 3.2 and 1.6-1.8 kb, that
hybridized to the probe appeared in ONS-76 cells as well as other
human cell lines (Hovanessian, 1991). Induction of 2-5 A
synthetase mRNA by IFN- was observed earlier in RI cells than in
C-76 cells, whereas it was lower in R2 cells than in C-76 cells at all
time periods. The kinetics ofmRNA induction in R1 cells exhibited
the maximum at 6 h and then a gradual decrease; in contrast, that of
C-76 and R2 cells increased more slowly (Figure SB). On the other
hand, C-76, RI and R2 cells were treated for 24 h with 300 or 3000
U ml-' of IFN-P, and the cell-surface expression of MHC class I
antigens by IFN-f was measured using flow cytometric analysis
(Figure 6). Without IFN-P treatment, expression of MHC class I
antigens was higher in R1 cells and lower in R2 cells than in C-76
cells (Table 2). With 300 U ml-' IFN-P treatment, expression of
MHC class I antigen was elevated in C-76 or in RI cells compared
with that ofthe respective uninduced cells, whereas R2 cells had no
significant change in the fold induction. In the presence of
3000 U mll ofIFN-3, which was more markedly elevated in all the
type of cells than in the case of 300 U ml IFN-3, RI cells
increased 3.73-fold more than the uninduced RI cells. In contrast,
R2 cells showed least responses to the IFN-P treatment. These
results indicate that IRF-1 may function as an activatorand IRF-2 as
a repressor ofexpression of2-5 A synthetase and MHC class I anti-
gens in CNS-derived cells.
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DISCUSSION
In the present study, CNS-derived ONS-76 cells were demon-
strated to possess IFN responses as well as fibroblasts; IFN-4 and
IFN-inducible genes were induced by viral infection and IFN-f
stimulation respectively. Furthermore, we found that the expres-
sion of IRF- 1 and IRF-2 was regulated in ONS-76 cells upon viral
infection and IFN-4 stimulation, and that overexpression of IRF- 1
and IRF-2 affected the regulation of the expression of IFN-3 and
IFN-inducible genes. These results suggest that both IRF-1 and
IRF-2 may function as regulators of IFN responses also in the
CNS. Compared with fibroblasts, the delayed induction of IRF-1
after IFN treatment (Figure 1) and the slower migrating band reac-
tive anti-IRF-2 antibody (Figure 2B) were newly observed in our
model system (Harada et al, 1990; Reis et al, 1992). Further inves-
tigation will be necessary to examine whether these phenomena
are unique to CNS-derived cells. As mentioned in previous reports
(Fujita et al, 1989a; Harada et al, 1990; Reis et al, 1992;
Matsuyama et al, 1993), IRF- I acts as a transcriptional activator of
IFN-, and IFN-inducible genes, and IRF-2 acts as a repressor of
IRF-mediated activation. However, in our study, overexpression of
IRF-2 up-regulated IFN-f gene expression and resulted in higher
production of IFN-1 by viral infection (Figure 3). This evidence
shows that IRF-2 as well as IRF- acts as a transcriptional acti-
vator of the IFN-P gene upon viral infection. That the functional
change also occurred in the presence of CHX (Figure 4) implied
that IRF-2 may directly convert to an activator. From our present
study, it is still unclear whether the activation ofthe IFN-f gene by
IRF-2 is only limited in CNS-derived cells. On the other hand, the
human histone H4 gene F0108 has been shown to be activated by
IRF-2 by using cDNA overexpression study (Vaughan et al, 1995).
This evidence may suggest that there exists a possible mechanism
by which IRF-2 functions as a transcriptional activator. Although
the mechanism by which IRF-2 activates the IFN-P gene expres-
sion is still unclear, some possible explanations are as follows.
(l) It has been reported that IRF-2 protein is truncated during
viral infection (Palombella and Maniatis, 1992), and trunca-
tion of carboxy-terminal repression domain of IRF-2 may
convert the function of IRF-2 to a transcriptional activator
(Yamamoto et al, 1994).
(2) It has been observed that the IFN-P gene expression is inhib-
ited by a protein kinase inhibitor, 2-aminopurine (Zinn et al,
1988). Viral-infection may induce some modification of IRF-
2 protein itself such as a phosphorylation, resulting in a func-
tional conversion of IRF-2.
(3) A factor(s) co-operates IRF-2 and activates the IFN-f gene
expression, such as IRF-2 associating molecule(s) or tran-
scription factor(s) including IRF- 1, which binds to the same
cis elements of IFN-,Bgene.
In our study, gel-shift assay showed a slower migrating band
that was not detected in fibroblasts (Figure 2B). The substance
may be the multiple form ofIRF-2, which might be involved in the
converting function of IRF-2. On the other hand, virally induced
IFN-f expression in C-76 cells was only detected at a very low
level when de novo protein synthesis was blocked by CHX,
whereas that in RI and R2 cells significantly increased more than
that in C-76 cells, particularly R1 cells that were much larger than
R2 cells (Figure 4). It was previously shown that IRF- protein
was unstable with a half-life of approximately 30 min and that
IRF-2 protein was apparently stable with a half-life of more than
8 h (Watanabe et al, 1991). Assuming that IRF-1 and IRF-2 are
equivalently co-operative for viral induction, different stabilities
might reflect upon different amounts of virally induced IFN-f
gene expression between R1 and R2 cells underCHX treatment. In
either case, the function of IRF-2 as a regulator of the IFN system
in CNS-derived cells is supposed to be more complex than that in
fibroblasts. Further studies in the future are needed to understand
the role of IRF-2 in the regulation ofIFN-P gene induction.
Our overexpression assays showed that IRF-I acted as an acti-
vator and IRF-2 acted as a repressor in the regulation of IFN-
inducible gene expression (Figures 5 and 6). These results agreed
with previous reports (Fujita et al, 1989a; Harada et al, 1990; Reis
et al, 1992; Matsuyama et al, 1993). However, as shown in Figure
5A and B, 2-5 A synthetase induction by IFN stimulation in RI
cells decreased after the maximum. This suppression was a novel
finding in our model system. On the other hand, embryonic fibro-
blasts from mice with a null mutation in the IRF-1 gene showed no
significant changes in the induction ofIFN-inducible genes, such as
2-5 A synthetase or double-stranded RNA-dependent protein
kinase under IFN stimulation (Kimura et al, 1994). This evidence
demonstrates the existence of IRF-I independent pathway in the
expression ofIFN-inducible genes. In fact, IFN-inducible genes are
known to be activated by a family ofISGF-3 (IFN-stimulated gene
factor-3) including Stat (signal transducer and activator of tran-
scription) proteins (Darnell et al, 1994). Many cytokines, including
IFNs, exhibit a wide range of biological effects in various tissues
and cells, whereas different cytokines can act on the same cells type
to mediate similar effects (Weissmann and Weber, 1986; Vilcek,
1990). This functional pleiotropy and redundancy may be
explained in part by the existence of diverse and shared transcrip-
tion factors in cytokine signalling. Thus, we have been much
concerned with the involvement of other transcriptional factors
such as ISGF-3 in IFN-inducible gene expression in CNS because
IFNs exhibit specific effects on neuronal cells (Calvet and Gresser,
1979; D'Arcangelo et al, 1991) and other transcriptional factors
may provide a clue to a mechanism for the suppression of 2-5 A
synthetase after the maximal induction (Figure 5B).
It has been identified that IRF-1 functions as a tumour
suppressor (Harada et al, 1993; Tanaka et al, 1994), and that IRF-I
regulates critical target genes that regulate cell cycle and apoptosis
(Tanaka et al, 1994; 1996: Tamura et al, 1995). This notion is also
supported by the fact that deletion of one or both alleles of the
IRF-1 gene was observed in many human leukaemia, myelo-
dysplasia and oesophageal carcinomas (Willman et al, 1993;
Ogasawara et al, 1996), and that functional loss of IRF-I by aber-
rant exon skipping was observed in myelodysplasia (Harada et al,
1994). In our study, we found that IRF-I and IRF-2 may regulate
IFN responses in CNS but that overexpression ofIRF-1 and IRF-2
did not effect upon cell growth and phenotypes of ONS-76 cell
line (data not shown). However, it will be interesting to analyse the
role of IRF-I and IRF-2 in oncogenesis ofCNS-derived cells such
as medulloblastoma or glioblastoma and to investigate critical
target genes of IRF-1 and IRF-2 in CNS in the near future.
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